The UK Health Security Agency (UKHSA) has released a new tool that will help research and development efforts of diagnostics, vaccines, and treatments for pathogens that pose the greatest risk to public health.
Long-term COVID-19 effects have been decreased from anywhere between 50 and 80% for those who have been vaccinated when compared to unvaccinated people.
Using almost $30 million in funding, an all-in-one vaccine is being developed to bring new protection against a range of new and existing coronavirus variants.
The most recent omicron subvariants have caused new infection spikes across the United States, as researchers find they are better at eluding vaccines.
